MyFinsight
Home
Blog
About
Contact
Marketable securities -
short term
$228,638K
Cash and cash
equivalents
$29,827K
Prepaid and other
current assets
$10,638K
Investment tax credits
receivable
$822K
Restricted investments
$75K
Total current assets
$270,000K
Marketable securities -
long term
$26,709K
Operating lease right of
use asset
$7,105K
Property and equipment,
net
$2,335K
Other assets
$1,375K
Total assets
$307,524K
Total liabilities and
shareholders' equity
$307,524K
Total shareholder's
equity
$255,168K
Liabilities, total
$52,356K
Accumulated deficit
-$432,011K
Accumulated other
comprehensive loss
-$1,141K
Common shares, no par
value unlimited...
$631,995K
Note payable, net of
current portion
$24,910K
Total current
liabilities
$21,485K
Operating lease
liabilities, net of current...
$5,961K
Additional paid-in capital
$56,325K
Accrued expenses and
other current...
$17,212K
Operating lease
liabilities, current
$2,287K
Accounts payable
$1,793K
Current portion of note
payable
$193K
Back
Back
Balance Sheet
enGene Therapeutics Inc. (ENGNW)
enGene Therapeutics Inc. (ENGNW)
source: myfinsight.com